EA
SGYP

Emerald Acquisition’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Emerald Acquisition’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.04M Buy
+189,151
New +$886K ﹤0.01% 2111

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Emerald Acquisition's SGYP Position: Q3 2016 in Review

Emerald Acquisition opened a new position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2016: 189,151 shares worth $1.04M. The stake represents ﹤0.01% of the portfolio and ranks #2111 among its holdings.

149 funds tracked by Wall St. Rank hold SGYP as of Q3 2016.

  • Emerald Acquisition held 189,151 shares of Synergy Pharmaceuticals, Inc Common Stock worth $1.04M as of Q3 2016.
  • Synergy Pharmaceuticals, Inc Common Stock was a new Emerald Acquisition position in Q3 2016.
  • Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2111 holding.
  • 149 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.